These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30774595)

  • 1. Assessing the 2004-2018 Fentanyl Misusing Issues Reported to an International Range of Adverse Reporting Systems.
    Schifano F; Chiappini S; Corkery JM; Guirguis A
    Front Pharmacol; 2019; 10():46. PubMed ID: 30774595
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS).
    Chiappini S; Vickers-Smith R; Guirguis A; Corkery JM; Martinotti G; Harris DR; Schifano F
    Pharmaceuticals (Basel); 2022 May; 15(6):. PubMed ID: 35745593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database.
    Chiappini S; Schifano F; Corkery JM; Guirguis A
    Brain Sci; 2020 Feb; 10(2):. PubMed ID: 32079135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases.
    Chiappini S; Vickers-Smith R; Guirguis A; Corkery JM; Martinotti G; Schifano F
    Pharmaceuticals (Basel); 2022 May; 15(5):. PubMed ID: 35631391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is There a Potential of Misuse for Venlafaxine and Bupropion?
    Schifano F; Chiappini S
    Front Pharmacol; 2018; 9():239. PubMed ID: 29618978
    [No Abstract]   [Full Text] [Related]  

  • 7. An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions.
    Schifano F; Chiappini S; Corkery JM; Guirguis A
    Int J Neuropsychopharmacol; 2019 Apr; 22(4):270-277. PubMed ID: 30722037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is medicinal ketamine associated with urinary dysfunction issues? Assessment of both the European Medicines Agency (EMA) and the UK Yellow Card Scheme pharmacovigilance database-related reports.
    Schifano N; Chiappini S; Castiglione F; Salonia A; Schifano F
    Low Urin Tract Symptoms; 2021 Apr; 13(2):230-237. PubMed ID: 33037767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-2 Agonists as Misusing Drugs? Assessment of both Clenbuterol- and Salbutamol-related European Medicines Agency Pharmacovigilance Database Reports.
    Milano G; Chiappini S; Mattioli F; Martelli A; Schifano F
    Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):182-187. PubMed ID: 29498199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond the 'purple drank': Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports.
    Chiappini S; Schifano F; Corkery JM; Guirguis A
    J Psychopharmacol; 2021 Jun; 35(6):681-692. PubMed ID: 33427017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reports of gabapentin and pregabalin abuse, misuse, dependence, or overdose: An analysis of the Food And Drug Administration Adverse Events Reporting System (FAERS).
    Evoy KE; Covvey JR; Peckham AM; Ochs L; Hultgren KE
    Res Social Adm Pharm; 2019 Aug; 15(8):953-958. PubMed ID: 31303196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse Drug Reactions to Opioids: A Study in a National Pharmacovigilance Database.
    Gustafsson M; Matos C; Joaquim J; Scholl J; van Hunsel F
    Drug Saf; 2023 Nov; 46(11):1133-1148. PubMed ID: 37824028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Online Conversation Monitoring to Understand the Opioid Epidemic: Epidemiological Surveillance Study.
    Black JC; Margolin ZR; Olson RA; Dart RC
    JMIR Public Health Surveill; 2020 Jun; 6(2):e17073. PubMed ID: 32597786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is There a Potential of Misuse for Quetiapine?: Literature Review and Analysis of the European Medicines Agency/European Medicines Agency Adverse Drug Reactions' Database.
    Chiappini S; Schifano F
    J Clin Psychopharmacol; 2018 Feb; 38(1):72-79. PubMed ID: 29210868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there such a thing as a 'lope' dope? Analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports.
    Schifano F; Chiappini S
    PLoS One; 2018; 13(10):e0204443. PubMed ID: 30286103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are finasteride-related penile curvature/Peyronie's disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases.
    Schifano N; Capogrosso P; Boeri L; Fallara G; Chiappini S; Rewhorn M; Cakir OO; Harvey H; Castiglione F; Alnajjar HM; Muneer A; Deho' F; Schifano F; Montorsi F; Salonia A
    Int J Impot Res; 2023 Aug; 35(5):465-471. PubMed ID: 35513712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [French trends in the misuse of Fentanyl: From 2010 to 2015].
    Tournebize J; Gibaja V; Frauger E; Authier N; Seyer D; Perri-Plandé J; Fresse A; Gillet P; Javot L; Kahn JP;
    Therapie; 2020; 75(5):491-502. PubMed ID: 31826806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug reaction reporting in the UK: a retrospective observational comparison of yellow card reports submitted by patients and healthcare professionals.
    McLernon DJ; Bond CM; Hannaford PC; Watson MC; Lee AJ; Hazell L; Avery A;
    Drug Saf; 2010 Sep; 33(9):775-88. PubMed ID: 20701410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacovigilance Reports Received from Children and Young People, and Development of Information to Aid Future Reporting from this Age Group.
    Bhoombla N; Preston J; Ainsworth J; Bird H; Jadeja M; King C; Hawcutt DB
    Paediatr Drugs; 2020 Jun; 22(3):335-341. PubMed ID: 32253722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system-active drug abused and overdose in children: a worldwide exploratory study using the WHO pharmacovigilance database.
    Carnovale C; Mahzar F; Scibelli S; Gentili M; Arzenton E; Moretti U; Leoni O; Pozzi M; Peeters GGAM; Clementi E; Medaglia M; Radice S
    Eur J Pediatr; 2019 Feb; 178(2):161-172. PubMed ID: 30374752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.